Venture Capital Investors

Cyclerion Therapeutics

Cyclerion Therapeutics is a VC investing group that helps tech entrepreneurs.

Venture Investor Overview

Venture Investor
Cyclerion Therapeutics
Status
InActive
Investor Type
Venture Capital
Activity Level
Funds Raised
Industry Focus
Biopharmaceutical

Contact Information

Contact
Peter Hecht
Title
Chief Executive Officer
Mailing Address
245 First Street Riverview II, 18th Floor
Cambridge, MA 02142
USA
Phone
Undisclosed
Email Address

Background Information

Overview
We are a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing innovative medicines for people with serious diseases of the central nervous system (CNS). Cyclerion was founded with the goal of unlocking the full therapeutic potential of the nitric oxide-cyclic guanosine monophosphate (cGMP) signaling pathway. Nitric oxide (NO) is one of several fundamental neurotransmitters, but it has yet to be leveraged for its full therapeutic potential in the central nervous system (CNS). As such, we believe our approach to enhancing NO-cGMP signaling -- sGC stimulation -- has broad potential to treat serious diseases of the CNS. We are excited and motivated by this opportunity to bring new medicines to patients in need.
Profile
Cyclerion Therapeutics LinkedIn Company Profile
Social Media
Cyclerion Therapeutics Company Twitter Account
Company News
Cyclerion Therapeutics News
Facebook
Cyclerion Therapeutics on Facebook
YouTube
Cyclerion Therapeutics on YouTube
Last Transaction
8/1/2023

Transaction History

Our records indicate that Cyclerion Therapeutics invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
8/1/2023
$81,000,000

 


Investor Contacts

Title
Name
Email & Social
Chief Operating Officer
Cheryl Gault
  Cheryl Gault LinkedIn Profile  Cheryl Gault Twitter Account  Cheryl Gault News  Cheryl Gault on Facebook
Chief Financial Officer
Anjeza Gjino
  Anjeza Gjino LinkedIn Profile  Anjeza Gjino Twitter Account  Anjeza Gjino News  Anjeza Gjino on Facebook
Chief Executive Officer
Peter Hecht
  Peter Hecht LinkedIn Profile  Peter Hecht Twitter Account  Peter Hecht News  Peter Hecht on Facebook

 


Funds

No fund closings have been recorded for this company.

 


Portfolio Companies

Cyclerion Therapeutics has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company

 

 


 

 

Browse more venture capital investors:

CYCLEffect Regenerative Ventures | Cyfr

 

Share this article

 


About Our VC Investors Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary